Long-term safety is not established, so any use should be considered experimental and approached with caution
A study found that subjects who used semaglutide for weight management reported significant reductions in body weight compared to those taking a placebo
While findings show an 8% reduction in triptan use among women and no significant change in men, experts believe anti-inflammatory properties and reduced intracranial pressure could be key
Available from: Accessed 10 Nov 2025
These drugs target almost all steps in the pathogenesis of NASH to improve insulin sensitivity, glucose and lipid metabolism, to inhibit de novo lipogenesis and delivery of lipids to the liver, and to influence apoptosis, inflammation and fibrogenesis
However, having a prescription label on the vial prevents discretionary delays if a screener questions the substance